Ignite Creation Date:
2025-12-25 @ 12:28 AM
Ignite Modification Date:
2026-01-03 @ 7:15 AM
Study NCT ID:
NCT06902467
Status:
RECRUITING
Last Update Posted:
2025-03-30
First Post:
2025-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer)
Sponsor:
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-27
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-15
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-24
First Submit QC Date:
None
Study First Post Date:
2025-03-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-28
Last Update Post Date:
2025-03-30
Last Update Post Date Type:
ACTUAL